Nautilus Biotechnology to Participate in the Goldman Sachs 45th Annual Global Healthcare Conference
23 Maggio 2024 - 2:00PM
Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a
company pioneering a single-molecule protein analysis platform,
today announced the company will be participating in the Goldman
Sachs 45th Annual Healthcare Conference.
Nautilus’ management is scheduled to participate in a fireside
chat on Monday, June 10, 2024, at 8:40 a.m. Eastern Time.
Interested parties may access a live and archived webcast of the
presentation on the “Investors” section of the company website at:
www.nautilus.bio.
About Nautilus Biotechnology, Inc.With its
corporate headquarters in Seattle, Washington and its research and
development headquarters in San Carlos, California, Nautilus is a
development stage life sciences company working to create a
platform technology for quantifying and unlocking the complexity of
the proteome. Nautilus’ mission is to transform the field of
proteomics by democratizing access to the proteome and enabling
fundamental advancements across human health and medicine. To learn
more about Nautilus, visit www.nautilus.bio.
Media Contactpress@nautilus.bio
Investor Contact
investorrelations@nautilus.bio
Grafico Azioni Nautilus Biotechnology (NASDAQ:NAUT)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Nautilus Biotechnology (NASDAQ:NAUT)
Storico
Da Giu 2023 a Giu 2024